| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316615 | Pancreatology | 2013 | 9 Pages |
Abstract
This quid pro quo of tumour cells and M2-macrophages could serve as a new target for future immunotherapies that interrupt tumour promoting activities of TAMs and change the iNOS-arginase balance towards their tumoricidal capacities.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
L.I. Partecke, C. Günther, S. Hagemann, C. Jacobi, M. Merkel, M. Sendler, N. van Rooijen, A. Käding, D. Nguyen Trung, E. Lorenz, S. Diedrich, F.U. Weiss, C.D. Heidecke, W. von Bernstorff,